| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT03022708 Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study |
Enrollment reduced: 56 -> 6 participants |
| 2026-07-30 | NCT06329310 Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study |
date change Primary completion pushed: 2025-12 -> 2027-07 |
| 2026-07-30 | NCT06329310 Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study |
date change Completion pushed: 2026-12 -> 2028-12 |
| 2026-07-30 | NCT04545112 Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) |
date change Primary completion pushed: 2026-03-15 -> 2027-02 |
| 2026-07-30 | NCT04545112 Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) |
date change Completion pushed: 2031-02-15 -> 2031-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-21 | NCT07716020 XPAD European Feasibility Study | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT06951685 | Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study | Peripheral Artery Occlusive Disease | Recruiting |
| NCT06329310 | Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study | End Stage Renal Disease | Recruiting |
| NCT04898153 | First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft | End Stage Renal Disease | Active, Not Recruiting |
| NCT05473299 | Xeltis Hemodialysis Access Graft: aXess Pivotal Study | End-stage Renal Disease | Active, Not Recruiting |
| NCT07716020 | XPAD European Feasibility Study | Peripheral Arterial Disease | Not Yet Recruiting |
| NCT04545112 | Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) | Multi Vessel Coronary Artery Disease | Enrolling by Invitation |
| NCT06494631 | Xeltis Hemodialysis Access Graft (aXess) US Study | End Stage Renal Disease | Enrolling by Invitation |
| NCT03022708 | Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study | Heart Defect, Congenital | Active, Not Recruiting |